Dividend Center Best Dividend Stocks

Best High Yield Dividend Stocks Dividend Aristocrats Dividend Stock Comparison

Dividend Calculator Dividend Returns Comparison Dividend Calendar

My Experts Top Analysts Top Financial Bloggers Top-Performing Corporate Insiders Top Hedge Fund Managers Top Research Firms Top Individual Investors

Personal Finance Center Mortgages Loans Investing & Retirement Spending & Savings

Calculators

401k Retirement Calculator Mortgage Calculator

Compound Interest Calculator Dollar Cost Averaging

Student Loan Calculator Auto Loan Calculator

Education

How To Use TipRanks TipRanks Labs Webinar Center Glossary FAQs

About Us

About TipRanks TipRanks Community Contact Us Careers Reviews Mobile APP

Working with TipRanks

Enterprise Solutions Top Online Brokers Become an Affiliate

Follow Us

TOOLS

Earnings Calendar

Daily Analyst Ratings

STOCKS

ADVANCED RESEARCH

TipRanks Premium

Invest Like a Pro with Unique Data & Simplifed ToolsTry Now

Dividend Center

Best Dividend Stocks

Best High Yield Dividend Stocks

Dividend Aristocrats

Dividend Stock Comparison

Dividend Calculator

Dividend Returns Comparison

Dividend Calendar

Top Financial Bloggers

Top-Performing Corporate Insiders

Top Hedge Fund Managers

Top Research Firms

Top Individual Investors

Personal Finance Center

Investing & Retirement

Spending & Savings

Calculators

Compound Interest Calculator

Mortgage Calculator

Auto Loan Calculator

Student Loan Calculator

401k Retirement Calculator

Enterprise Solutions

Plans & Pricing

Education

How To Use TipRanks

About Us

TipRanks Community

Working with TipRanks

Enterprise Solutions

Top Online Brokers

Become an Affiliate

Follow Us

Femasys (FEMY)

NASDAQ:FEMY

US Market

FEMY

Femasys

Analyst Forecasts

Technical Analysis

RESEARCH TOOLS

Top Analyst Stocks

Top Smart Score Stocks

reports

Femasys (FEMY) Stock News & Sentiment

271 Followers

Femasys Releases Updated Investor Presentation Information

PremiumCompany Announcements

Femasys Releases Updated Investor Presentation Information

2d ago

Femasys CEO and Founder Kathy Lee-Sepsick Meets with Members of Congress to Raise Awareness of the Company and Discuss Women’s Healthcare Initiatives

PremiumPress Releases

Femasys CEO and Founder Kathy Lee-Sepsick Meets with Members of Congress to Raise Awareness of the Company and Discuss Women’s Healthcare Initiatives

8d ago

Femasys Announces Financial Results for Year Ended December 31, 2023 and Provides Corporate Update

PremiumPress Releases

Femasys Announces Financial Results for Year Ended December 31, 2023 and Provides Corporate Update

28d ago

Femasys Invites Investors to View Fireside Chat Today, March 21, 2024, to Discuss the Infertility Treatment Landscape

PremiumPress Releases

Femasys Invites Investors to View Fireside Chat Today, March 21, 2024, to Discuss the Infertility Treatment Landscape

1M ago

Femasys Announces Positive Topline Data from Pivotal Trial for its FDA-Cleared FemaSeed® for the Treatment of Infertility

PremiumPress Releases

Femasys Announces Positive Topline Data from Pivotal Trial for its FDA-Cleared FemaSeed® for the Treatment of Infertility

1M ago

Is FEMY a Buy, Before Earnings?

PremiumPre-Earnings

Is FEMY a Buy, Before Earnings?

1M ago

Femasys Completes the First In-Office Commercial Procedure with the FDA-Cleared FemaSeed Infertility Solution

PremiumPress Releases

Femasys Completes the First In-Office Commercial Procedure with the FDA-Cleared FemaSeed Infertility Solution

2M ago

More FEMY News >

FEMY News on the Web

2024-04-18

Femasys CEO and Founder Kathy Lee-Sepsick Meets with Members of Congress to Raise Awareness of the Company and Discuss Women’s Healthcare Initiatives

Yahoo Finance

Neutral

2024-04-02

Femasys: A Buy Rating on Innovative Reproductive Solutions and Market Expansion Potential

TipRanks News

Bullish

2024-03-31

Femasys Full Year 2023 Earnings: EPS Beats Expectations, Revenues Lag

Yahoo Finance

Bearish

2024-03-29

FEMY Stock Earnings: Femasys Beats EPS, Misses Revenue for Q4 2023

InvestorPlace

Neutral

2024-03-28

Femasys Announces Financial Results for Year Ended December 31, 2023 and Provides Corporate Update

Yahoo Finance

Neutral

2024-03-21

Analysts Offer Insights on Healthcare Companies: Femasys (FEMY) and NextCure (NXTC)

TipRanks News

Bullish

2024-03-21

Femasys Invites Investors to View Fireside Chat Today, March 21, 2024, to Discuss the Infertility Treatment Landscape

Yahoo Finance

Neutral

2024-03-21

Premarket Mover: Femasys Inc (FEMY) Up 2.22%

Investors Observer

Neutral

News Score - Last 7 Days

Not enough data to generate a sentiment score

Media Buzz

This Week0 articles

Weekly Average0 articles

News Sentiment

Currently, no data available

See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is FEMY’s Media Buzz Sentiment?

Currently, no data Available

What is FEMY’s weekly average amount of articles?

Currently, no data Available

What is FEMY’s News Sentiment?

Currently, no data Available

Healthcare Stocks that are Trending in the News

DAWNDay One Biopharmaceuticals

NBIXNeurocrine

AMEDAmedisys

HSTMHealthStream

IMVTImmunovant

Showing the stocks with the most bullish news sentiment over the past week

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing